China mulls trillion-yuan fiscal stimulus: report

Beijing is considering injecting more than 1 trillion yuan ($16 billion) into the Chinese economy over the next three years, state news agency Xinhua said on Friday, citing a report from the China International Capital Corporation. According to the CICC report, the stimulus package will be between 1.2 trillion and 1.5 trillion yuan and is likely to drive a total potential investment of 5 trillion to 7 trillion yuan in the next three years. That’s as much as 3.4% of the 2015 gross domestic product each year. The investment projects will be funded by commercial lenders, private investors and policy banks, the report said. Earlier this week, China’s finance ministry said the country will roll out a “more forceful” fiscal policy to stimulate growth.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Winnebago interim CEO Olson to step down

Winnebago Industries Inc. said Thursday its interim Chief Executive Robert J. Olson will be stepping down Sept. 24. If the CEO position has not been filled by then, Chairman of the Board Larry Erickson will temporarily serve as chief executive. Shares of the motor-home manufacturer were flat in late trading Thursday after ending the regular session up 0.9%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Actelion and ZS Pharma confirm acquisition talks

Biopharmaceuticals giant Actelion Ltd. confirmed Thursday afternoon that it has held talks with potential acquisition target ZS Pharma Inc. Actelion, based in Switzerland, issued a brief statement that said it “has initiated preliminary discussions” with ZS Pharma, and that it would not give further comment. ZS Pharma issued a similar statement minutes later. “ZS Pharma regularly and routinely explores opportunities with various strategic partners and will continue to do so,” the statement read. “These discussions may or may not lead to any transaction.” Bloomberg News reported earlier Thursday that the two companies had discussed a deal that would value Texas-based ZS Pharma at $2.5 billion. ZS Pharma stock roared higher after the Bloomberg report, closing with a 28.4% gain at $74.73 that pushed the company’s market cap closer to $2 billion.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Private equity Siris to buy Premiere Global for $1 billion

Private-equity company Siris Capital Group has agreed to buy Premiere Global Services Inc. , or PGi, for about $1 billion, PGi said Thursday. Under the terms of the agreement, Siris will acquire all outstanding shares of the software company for $14 a share, a premium of 23% over PGi’s Thursday closing of $11.35. Shares of PGi soared 21% in after-hours trading after ending the regular session up 2.1%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Actelion confirms talks with ZS Pharma

Biopharmaceuticals giant Actelion Ltd. confirmed Thursday afternoon that it has held talks with potential acquisition target ZS Pharma Inc. Actelion, based in Switzerland, issued a brief statement that said it “has initiated preliminary discussions” with ZS Pharma, and that it would not give further comment. Bloomberg News reported earlier Thursday that the two companies had discussed a deal that would value Texas-based ZS Pharma at $2.5 billion. ZS Pharma stock roared higher after the Bloomberg report, closing with a 28.4% gain at $74.73 that pushed the company’s market cap closer to $2 billion.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

GE to sell transportation finance unit to BMO

General Electric Co. said Thursday it has agreed to sell the transportation finance unit of GE Capital to BMO Financial Group as the conglomerate continues to shed financial businesses in a quest to increase profits and focus on the industrial side. With this transaction, the total for 2015 sales is approximately $85 billion, GE said. “We expect to reach sales agreements for the majority of our U.S. businesses by the end of this year and the sale of the Transportation Finance business, one of our core commercial lending and leasing businesses, gets us closer to that goal,” GE Capital Chief Executive Keith Sherin said in a statement. Terms of the deal were not disclosed. Shares of GE rose 0.1% in late trading after ending the regular session up 0.5%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News